ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.150,71
-0,10%
S&P 500
5.303,27
0,12%
US Dollar vs BRL
5,1046
0,00%
Bitcoin
67.089,49
0,22%
Brent Oil
83,76
0,00%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. MacroGenics Inc (MGNX)

  7. MacroGenics Inc (MGNX) Notícias

MGNX

MacroGenics (MGNX)

MacroGenics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:MGNX
DataHoraFonteTítuloCódigoCompanhia
13/05/202408:30GlobeNewswire Inc.MacroGenics to Participate in Upcoming Investor ConferencesNASDAQ:MGNXMacroGenics Inc
09/05/202417:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGNXMacroGenics Inc
09/05/202417:02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MGNXMacroGenics Inc
09/05/202417:01GlobeNewswire Inc.MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim TAMARACK Phase 2 Study DataNASDAQ:MGNXMacroGenics Inc
03/05/202408:30GlobeNewswire Inc.MacroGenics Announces Date of First Quarter 2024 Financial Results Conference CallNASDAQ:MGNXMacroGenics Inc
03/04/202417:30GlobeNewswire Inc.MacroGenics Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future DisclosuresNASDAQ:MGNXMacroGenics Inc
08/03/202418:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGNXMacroGenics Inc
07/03/202418:01GlobeNewswire Inc.MacroGenics Provides Update on Corporate Progress and 2023 Financial ResultsNASDAQ:MGNXMacroGenics Inc
06/03/202418:16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MGNXMacroGenics Inc
27/02/202419:45GlobeNewswire Inc.MacroGenics Announces Date of Fourth Quarter 2023 Financial Results Conference CallNASDAQ:MGNXMacroGenics Inc
14/02/202419:01Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MGNXMacroGenics Inc
14/02/202412:04Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:MGNXMacroGenics Inc
02/02/202418:30GlobeNewswire Inc.MacroGenics to Participate in Upcoming Investor ConferenceNASDAQ:MGNXMacroGenics Inc
16/11/202302:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MGNXMacroGenics Inc
06/11/202318:09Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:MGNXMacroGenics Inc
06/11/202318:01GlobeNewswire Inc.MacroGenics Provides Update on Corporate Progress and Third Quarter 2023 Financial ResultsNASDAQ:MGNXMacroGenics Inc
31/10/202317:30GlobeNewswire Inc.MacroGenics Announces Date of Third Quarter 2023 Financial Results Conference CallNASDAQ:MGNXMacroGenics Inc
05/09/202308:00GlobeNewswire Inc.MacroGenics Announces Achievement of $15 Million Milestone Related to Gilead’s Nomination of a Bispecific Research ProgramNASDAQ:MGNXMacroGenics Inc
09/08/202317:01GlobeNewswire Inc.MacroGenics Provides Update on Corporate Progress and Second Quarter 2023 Financial ResultsNASDAQ:MGNXMacroGenics Inc
31/07/202318:35GlobeNewswire Inc.MacroGenics Announces Date of Second Quarter 2023 Financial Results Conference CallNASDAQ:MGNXMacroGenics Inc
02/06/202317:59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MGNXMacroGenics Inc
02/06/202309:40Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MGNXMacroGenics Inc
09/05/202317:01GlobeNewswire Inc.MacroGenics Provides Update on Corporate Progress and First Quarter 2023 Financial ResultsNASDAQ:MGNXMacroGenics Inc
04/05/202317:30GlobeNewswire Inc.MacroGenics Announces Date of First Quarter 2023 Financial Results Conference CallNASDAQ:MGNXMacroGenics Inc
28/04/202307:23Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:MGNXMacroGenics Inc
19/04/202317:06Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:MGNXMacroGenics Inc
17/04/202317:26Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:MGNXMacroGenics Inc
22/03/202315:19Dow Jones NewsIncyte Gets FDA Approval of Zynyz, Triggers Milestone Payment to MacroGenicsNASDAQ:MGNXMacroGenics Inc
22/03/202314:22GlobeNewswire Inc.MacroGenics Earns $15 Million Milestone Following U.S. FDA Approval of ZYNYZ™ (retifanlimab-dlwr)NASDAQ:MGNXMacroGenics Inc
15/03/202318:21Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:MGNXMacroGenics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:MGNX

Seu Histórico Recente

EU
ISPY
L&G Cyber Security UCITS...
BIT
S28730
Societe Generale Effekten
BIT
P1VX57
NLBNPIT1VX57 20991231 12...
BIT
P228T2
NLBNPIT228T2 20991231 21...
ASX
FTE
Forte Energy
ASX
NNG
Nexion
BIT
F18435
Vontobel Financial Produ...
GATE
TWITFIUSDT
TwitFi Token
BIT
S28239
Societe Generale Effekten
LSE
DRTE
COIN
SCATUSD
Sad Cat Token
COIN
CANETETH
NASDAQ
CAFN
BIT
P1WF66
NLBNPIT1WF66 20351221 11...
ASX
ARGJOZ
EU
E952S
E952S
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados